Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease: Implications for Dose Adaptation

Author： Schlatter Chantal   Egger Sabin S.   Tchambaz Lydia   Krähenbühl Stephan  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.32, Iss.7, 2009-07, pp. : 561-578

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose Adaptation of Antineoplastic Drugs in Patients with Liver Disease

By Tchambaz Lydia  

Drug Safety, Vol. 29, Iss. 6, 2006-01 ,pp. : 509-522

Adis International

Access to resources Recommend Favorite

Excretion of Psychotropic Drugs into Breast Milk: Pharmacokinetic Overview and Therapeutic Implications

By Spigset O.  

CNS Drugs, Vol. 9, Iss. 2, 1998-02 ,pp. : 111-134

Adis International

Access to resources Recommend Favorite

Dose Adjustment in Patients with Liver Disease

By Delcò Fabiola   Tchambaz Lydia   Schlienger Raymond   Drewe Jürgen   Krähenbühl Stephan  

Drug Safety, Vol. 28, Iss. 6, 2005-01 ,pp. : 529-545

Adis International

Access to resources Recommend Favorite

Dose adjustment of drugs with high hepatic extraction are required in patients with severe liver disease

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 5, 2006-05 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease

By Scheen André J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 6, 2014-06 ,pp. : 839-857

Informa Healthcare

Access to resources Recommend Favorite